These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 10939782)

  • 21. [Hypertension, heart failure, myocardial infarction, secondary prevention: the role of perindopril].
    Rapezzi C; Ciliberti P; Graziosi M; Riva L
    Ital Heart J; 2005 Nov; 6 Suppl 7():40S-47S. PubMed ID: 16485516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin-converting enzyme inhibition by perindopril in the treatment of cardiovascular disease.
    Brugts JJ; Ferrari R; Simoons ML
    Expert Rev Cardiovasc Ther; 2009 Apr; 7(4):345-60. PubMed ID: 19379059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Global impact of stroke.
    Chalmers J
    Heart Dis; 2000; 2(2):S13-7. PubMed ID: 11728258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antihypertensive and lipid lowering treatment in stroke prevention: current state and future.
    Piechowski-Jóźwiak B; Bogousslavsky J
    Acta Neurol Belg; 2005 Jun; 105(2):57-61. PubMed ID: 16076057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blockage of the renin-angiotensin system in the secondary prevention of stroke: beneficial effects beyond blood pressure reduction?
    Castilla-Guerra L; del Carmen Fernández-Moreno M; Jiménez-Hernandez MD
    Stroke; 2009 Mar; 40(3):e75; author reply e76. PubMed ID: 19182077
    [No Abstract]   [Full Text] [Related]  

  • 26. Combination of the angiotensin-converting enzyme inhibitor perindopril and the diuretic indapamide activate postnatal vasculogenesis in spontaneously hypertensive rats.
    You D; Cochain C; Loinard C; Vilar J; Mees B; Duriez M; Lévy BI; Silvestre JS
    J Pharmacol Exp Ther; 2008 Jun; 325(3):766-73. PubMed ID: 18309090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Need of tight blood pressure control in type 2 diabetes. The intervention study ADVANCE gives clear information].
    Nilsson PM
    Lakartidningen; 2007 Oct 17-23; 104(42):3028-9. PubMed ID: 17985709
    [No Abstract]   [Full Text] [Related]  

  • 28. [Do converting enzyme inhibitors give a better protection against cerebral vascular complications in hypertensive patients?].
    Capdeville C; Boulu RG; Atkinson J
    Therapie; 1988; 43(4):247-9. PubMed ID: 3055403
    [No Abstract]   [Full Text] [Related]  

  • 29. Blood pressure control and prevention of stroke.
    Karthikeyan VJ; Lip GY
    Expert Rev Neurother; 2006 Feb; 6(2):203-12. PubMed ID: 16466300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Type 2 diabetes. Routine ACE inhibitors?].
    Hönl SB
    Med Monatsschr Pharm; 2008 Apr; 31(4):149-50. PubMed ID: 18497249
    [No Abstract]   [Full Text] [Related]  

  • 31. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
    Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
    Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination BP therapy cuts second stroke risk in half.
    Geriatrics; 2001 Aug; 56(8):14, 16. PubMed ID: 11505852
    [No Abstract]   [Full Text] [Related]  

  • 33. Very-low-dose combination of perindopril and indapamide as a novel strategy in first-line management of hypertension.
    de Leeuw PW; ;
    J Hypertens Suppl; 2001 Sep; 19(3):S41-5. PubMed ID: 11713850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypertension arm of ADVANCE defines extent of renal protection using perindopril/indapamide in type 2 diabetics.
    Cardiovasc J Afr; 2008; 19(4):226. PubMed ID: 18776973
    [No Abstract]   [Full Text] [Related]  

  • 35. Angiotensin-converting enzyme inhibition in cardiovascular disease: evidence with perindopril.
    Ferrari R
    Expert Rev Cardiovasc Ther; 2005 Jan; 3(1):15-29. PubMed ID: 15723572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An economic evaluation of a perindopril-based blood pressure lowering regimen for patients who have suffered a cerebrovascular event.
    Tavakoli M; Pumford N; Woodward M; Doney A; Chalmers J; MacMahon S; Macwalter R
    Eur J Health Econ; 2009 Feb; 10(1):111-9. PubMed ID: 18446392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pulse wave velocity and urinary albumin excretion in hypertensive patients treated with perindopril].
    Negri AL
    Medicina (B Aires); 2003; 63(4):363. PubMed ID: 14518154
    [No Abstract]   [Full Text] [Related]  

  • 38. Systolic hypertension.
    Nash DT
    Geriatrics; 2006 Dec; 61(12):22-8. PubMed ID: 17184139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypertension and cerebrovascular disease.
    Breslin DJ; Swinton NW
    Prim Care; 1980 Mar; 7(1):49-58. PubMed ID: 6901185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypertension, stroke, and noncompliance: an avoidable triad.
    Futterman LG; Lemberg L
    Am J Crit Care; 1996 May; 5(3):227-33. PubMed ID: 8722926
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.